Delivery Order SPE2DB20D1100-SPE2DB24FD0P5

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,562,345,930 units of the medication Varenicline 0.5 mg tablets. The $27,121.75 contract has an ultimate completion date of October 2, 2023 and is not designated as a set-aside. This contract is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract valued at $1,673.82 for the supply of 4,565,031,699 units of the drug varenicline 1 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a wide range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, to supply the U.S. Department of Defense with varenicline 0.5 mg tablets. The contract has a ceiling value of $2,522.62 and a period of performance through March 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00...
This is a $3,880.42 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 56-count packages of the prescription drug varenicline 1 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order, valued at $2,040.72, is for the supply of 56 tablets of Varenicline 1 mg, a prescription medication. The delivery order was issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of 56 tablets of the medication varenicline 0.5 mg, with a potential value of $1,137.16 and a completion date of March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 56 tablets of the drug varenicline with a 1 mg dosage. The contract has a ceiling value of $11,658.26 and is a firm fixed-price delivery order with a completion date of May 9, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,137.58 firm fixed-price delivery order is for the supply of 56 count tablets of the medication varenicline, with an ultimate completion date of October 13, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,194.05 Firm Fixed Price delivery order is for the supply of 4562474272 Varenicline 1 mg Tablets, a prescription medication. The order has an ultimate completion date of October 16, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 56 count packages of the pharmaceutical product varenicline 1 mg tablets. The contract has a completion date of February 20, 2024 and a potential value of $3,410.85. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and is delivering the pharmaceutical products to support...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD0P5
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,707.60 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 56 tablets of the prescription medication varenicline 1 mg. This delivery order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, in support of military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by August 2, 2024.

Generated 10/31/24, 9:42 AM